Abstract Background and aims: The occurrence rate of adverse events (AEs) related to care among hospitalized oncology patients in Switzerland remains unknown. The primary objective of this study was to describe, for the first time, the occurrence rate, type, severity of harm, and preventability of AEs related to care, reported in health records of hospitalized hematological and solid-tumor cancer patients in three Swiss hospitals. Methods: Using an adapted version of the validated Global Trigger Tool (GTT) from the Institute for Healthcare Improvement, we conducted a retrospective record review of patients discharged from oncology units over a 6-week period during 2018. Our convenience sample included all records from adult patients (≥18 ye...
Introduction: Adverse Drug Reactions (ADRs) are common in hospitalized oncology patients. The kinds ...
Background: Medication-related adverse events (MRAEs) form a large proportion of all adverse events ...
BACKGROUND: Medication-related adverse events (MRAEs) form a large proportion of all adverse events ...
Background and aims : The occurrence rate of adverse events (AEs) related to care among hospitalized...
The occurrence rate of adverse events (AEs) related to care among hospitalized oncology patients in ...
Background: Patients with cancer are often treated by many healthcare providers, receive complex and...
AIMS: The purpose of the study was to describe the type, prevalence, severity and preventability of ...
AIMS The purpose of the study was to describe the type, prevalence, severity and preventability o...
“First, do no harm” is a fundamental element of health care and considered indistinguishable from th...
Objectives: To describe the level, preventability and categories of adverse events (AEs) identified ...
International audienceAbstract Background: Drug-related iatrogenic effects are common in oncology be...
Abstract Objective Retrospective records reviews carried out in several countries have shown substan...
Retrospective records reviews carried out in several countries have shown substantial rates of adver...
Abstract Background Adverse events (AEs) seriously affect patient safety and quality of care, and re...
Abstract Book of the 44th ESMO Congress (ESMO 2019) 27 September – 1 October 2019, Barcelona, Spai
Introduction: Adverse Drug Reactions (ADRs) are common in hospitalized oncology patients. The kinds ...
Background: Medication-related adverse events (MRAEs) form a large proportion of all adverse events ...
BACKGROUND: Medication-related adverse events (MRAEs) form a large proportion of all adverse events ...
Background and aims : The occurrence rate of adverse events (AEs) related to care among hospitalized...
The occurrence rate of adverse events (AEs) related to care among hospitalized oncology patients in ...
Background: Patients with cancer are often treated by many healthcare providers, receive complex and...
AIMS: The purpose of the study was to describe the type, prevalence, severity and preventability of ...
AIMS The purpose of the study was to describe the type, prevalence, severity and preventability o...
“First, do no harm” is a fundamental element of health care and considered indistinguishable from th...
Objectives: To describe the level, preventability and categories of adverse events (AEs) identified ...
International audienceAbstract Background: Drug-related iatrogenic effects are common in oncology be...
Abstract Objective Retrospective records reviews carried out in several countries have shown substan...
Retrospective records reviews carried out in several countries have shown substantial rates of adver...
Abstract Background Adverse events (AEs) seriously affect patient safety and quality of care, and re...
Abstract Book of the 44th ESMO Congress (ESMO 2019) 27 September – 1 October 2019, Barcelona, Spai
Introduction: Adverse Drug Reactions (ADRs) are common in hospitalized oncology patients. The kinds ...
Background: Medication-related adverse events (MRAEs) form a large proportion of all adverse events ...
BACKGROUND: Medication-related adverse events (MRAEs) form a large proportion of all adverse events ...